文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

联合超声造影、CT灌注成像及锝- sestamibi SPECT/CT对一例肾实性肿瘤进行诊断指导

Combining contrast-enhanced ultrasound, CT perfusion and Tc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour.

作者信息

Kalarakis Georgios, Brehmer Katharina, Svensson Anders, Axelsson Rimma, Brismar Torkel B, Tzortzakakis Antonios

机构信息

Department of Radiology, Karolinska University Hospital, Huddinge, Stockholm, Sweden.

出版信息

BJR Case Rep. 2020 Sep 4;7(1):20200115. doi: 10.1259/bjrcr.20200115. eCollection 2021 Feb 1.

DOI:10.1259/bjrcr.20200115
PMID:33614118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7869121/
Abstract

Definitive, pre-operative differentiation of solid renal lesions by ultrasound, contrast-enhanced multiphasic CT or MRI examinations is often not possible. An increasing amount of literature indicates the added value of Tc-Sestamibi SPECT/CT, CT perfusion and contrast-enhanced ultrasound in the pre-operative characterisation of solid renal tumours. This case report presents the diagnostic approach of a solid renal tumour that turned out to be a hybrid oncocytic chromophobe tumour in a patient with Stage 3 renal failure by combining the three aforementioned modern examination techniques.

摘要

通过超声、多期增强CT或MRI检查对实性肾病变进行明确的术前鉴别往往是不可能的。越来越多的文献表明，Tc-司他米比SPECT/CT、CT灌注成像和超声造影在实性肾肿瘤术前特征描述方面具有附加价值。本病例报告介绍了一名3期肾衰竭患者的实性肾肿瘤的诊断方法，该肿瘤通过结合上述三种现代检查技术，最终被诊断为混合性嗜酸性嫌色细胞瘤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/25228288b9df/bjrcr.20200115.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/eb2967034094/bjrcr.20200115.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/706b4100b884/bjrcr.20200115.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/25228288b9df/bjrcr.20200115.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/eb2967034094/bjrcr.20200115.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/706b4100b884/bjrcr.20200115.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/591b/7869121/25228288b9df/bjrcr.20200115.g003.jpg

相似文献

[1]
Combining contrast-enhanced ultrasound, CT perfusion and Tc-Sestamibi SPECT/CT to guide diagnosis in a case of solid renal tumour.

BJR Case Rep. 2020-9-4

[2]
In Situ Metabolomics Expands the Spectrum of Renal Tumours Positive on Tc-sestamibi Single Photon Emission Computed Tomography/Computed Tomography Examination.

Eur Urol Open Sci. 2020-11-27

[3]
Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of Tc-sestamibi SPECT/CT.

EJNMMI Res. 2017-12

[4]
Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.

Eur Urol. 2015-9-18

[5]
Machine Learning Integrating Tc Sestamibi SPECT/CT and Radiomics Data Achieves Optimal Characterization of Renal Oncocytic Tumors.

Cancers (Basel). 2023-7-9

[6]
Use of quantitative SPECT/CT reconstruction in Tc-sestamibi imaging of patients with renal masses.

Ann Nucl Med. 2018-2

[7]
Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.

Clin Nucl Med. 2017-4

[8]
Correlation of Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression.

EJNMMI Res. 2017-10-2

[9]
Use of Tc-sestamibi Single-photon Emission Computed Tomography / X-ray Computed Tomography in the Diagnosis of Hybrid Oncocytic / Chromophobe Tumor in a Pediatric Patient.

Urology. 2018-3

[10]
Characterizing Indeterminate Renal Masses with Molecular Imaging: the Role of Tc-MIBI SPECT/CT.

Curr Urol Rep. 2017-9-12

引用本文的文献

[1]
A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia.

Sci Rep. 2023-8-3

本文引用的文献

[1]
Renal Oncocytoma: An Algorithm for Diagnosis and Management.

Urology. 2020-9

[2]
Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis.

Abdom Radiol (NY). 2020-8

[3]
Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma.

Abdom Radiol (NY). 2019-10

[4]
Contrast-enhanced ultrasound for characterizing renal masses.

Eur J Radiol. 2018-5-16

[5]
Evaluation of renal lesions using contrast-enhanced ultrasound (CEUS); a 10-year retrospective European single-centre analysis.

Eur Radiol. 2018-5-9

[6]
CT and MRI of small renal masses.

Br J Radiol. 2018-7

[7]
The role of molecular imaging in the characterization of renal masses.

Curr Opin Urol. 2018-3

[8]
Tc-sestamibi SPECT/CT for the characterization of renal masses: a pictorial guide.

Br J Radiol. 2018-4

[9]
Correlation of Tc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression.

EJNMMI Res. 2017-10-2

[10]
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.

Eur Urol. 2016-2-28

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索